[Form 4/A] Iridex Corp Amended Insider Trading Activity

Rhea-AI Filing Summary

Iridex Corp CFO Romeo R. Dizon filed an amended Form 4 reporting two significant equity transactions on June 13, 2025:

• Acquired 22,500 Restricted Stock Units (RSUs) at $0.94 per share, with vesting over three years starting June 13, 2026 (one-third annually)
• Received stock options to purchase 75,000 shares of common stock at an exercise price of $0.94, vesting over three years and expiring June 13, 2032

Following these transactions, Dizon directly owns 37,745 shares and 75,000 stock options. This amended filing corrects a previous Form 4 filed on June 17, 2025. The equity awards were granted under the company's 2008 Equity Incentive Plan and are exempt under Rule 16b-3. These grants appear to be part of executive compensation arrangements, demonstrating long-term alignment with shareholder interests through multi-year vesting schedules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/17/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/13/2025		A		22,500(1)	A	$0.94	37,745	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (right to buy)(2)	$0.94	06/13/2025		A		75,000		(3)	06/13/2032	Common Stock	75,000	$0	75,000	D

Explanation of Responses:

1. Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest as to one-third of the shares on June 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

2. This option was granted pursuant to the Company's 2008 Equity Incentive Plan, as amended, and is exempt pursuant to Rule16b-3.

3. The shares are subject to vesting according to the following schedule: 1/3 of the Shares subject to the Option will vest each one-year anniversary of the date of grant.

	/s/ Nilo De Castro, Attorney-in-fact for Romeo Dizon	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock options did IRIX CFO Romeo Dizon receive on June 13, 2025?

IRIX CFO Romeo Dizon received 75,000 stock options on June 13, 2025, with an exercise price of $0.94 per share. These options vest over three years, with 1/3 of the shares vesting each year on the anniversary of the grant date. The options expire on June 13, 2032.

How many restricted stock units (RSUs) were granted to IRIX's CFO in June 2025?

Romeo Dizon was granted 22,500 restricted stock units (RSUs) on June 13, 2025. Each RSU represents one share of IRIX common stock. The RSUs vest over three years, with one-third vesting on June 13, 2026, and each one-year anniversary thereafter, subject to continued service.

What is the total IRIX stock ownership of CFO Romeo Dizon after the June 2025 grants?

Following the reported transactions, Romeo Dizon directly owns 37,745 shares of IRIX common stock, plus 75,000 unvested stock options and 22,500 unvested RSUs granted on June 13, 2025.

Why did IRIX file a Form 4/A amendment for CFO Romeo Dizon?

The Form 4/A was filed as an amendment to the original Form 4 filed on June 17, 2025, reporting stock option and RSU grants to CFO Romeo Dizon. The amendment was filed on June 28, 2025, though the specific changes from the original filing are not detailed in the document.